LatestWhat is emotional regulation? A child psychologist explains
Cannabis

Senate Passes Spending Bill With One-Month Delay to Federal Hemp Crackdown

Cannabis Now
Senate Passes Spending Bill With One-Month Delay to Federal Hemp Crackdown
Summary

The U.S. Senate passed a government funding bill on August 8th that delays sweeping federal restrictions on hemp-derived THC products by approximately one month. The stopgap spending measure passed with a 90-6 vote, providing the nation's hemp industry a critical reprieve before new federal regulations take effect. This delay gives policymakers, industry stakeholders, and medical patients additional time to prepare for potential changes to hemp product availability and regulations. For Puerto Rico residents who rely on hemp-derived cannabinoid products, this development provides a window to understand how upcoming federal restrictions may impact local access and availability.

Cannabis Now

Originally published on

Cannabis Now

By Cannabis Now

Read full article(opens in new tab)

Fetched: August 9, 2026 at 10:02 AM

Related News

More news you might be interested in

View all
Cannabis

Rhode Island Reopens Adult-Use Cannabis Retail License Applications

Rhode Island has reopened applications for adult-use cannabis retail licenses, establishing specific deadlines for both general applicants and social equity candidates. This regulatory development expands access to legal cannabis markets and provides opportunities for entrepreneurs and individuals from communities disproportionately affected by cannabis prohibition. The reopened application window represents an important step in Rhode Island's cannabis legalization framework, allowing qualified businesses to enter the regulated market. For patients and consumers, expanded retail availability means improved legal access to cannabis products that may support various health conditions under medical supervision.

8 hours ago
Cannabis Magazine
Cannabis

U.S. Senate Extends THC-Hemp Provision in Budget Resolution

The U.S. Senate rejected an amendment to restrict hemp-derived THC products and approved a budget resolution that maintains a temporary extension of the current regulatory framework. This decision allows continued access to hemp-derived cannabinoids, including delta-8 and delta-10 THC, which remain in legal gray areas at the federal level. The extension provides temporary stability for the hemp industry and consumers seeking cannabinoid-based products, though long-term clarification of federal hemp regulations remains pending. For patients exploring cannabinoid therapies, this development maintains marketplace availability while regulatory clarity continues to evolve.

8 hours ago
Cannabis Magazine
Rhode Island Restarts Marijuana Retail Licensing After Court Case Ends
Cannabis

Rhode Island Restarts Marijuana Retail Licensing After Court Case Ends

Rhode Island's Cannabis Control Commission has reopened applications for prospective marijuana retailers following the conclusion of litigation that had blocked the state's initial licensing effort. The regulatory body aims to implement the amended Cannabis Act efficiently and maintain momentum in establishing a legal, regulated cannabis market. This restart allows new applicants to participate in the licensing process that was previously halted by a federal court order. The reopened process represents a significant step forward in Rhode Island's medical and adult-use cannabis program, which provides regulated access for patients with qualifying conditions and adult consumers seeking standardized, tested products.

20 hours ago
Marijuana Moment
Senate Delays Hemp THC Ban, Giving Lawmakers Time to Establish Legal Regulations
Cannabis

Senate Delays Hemp THC Ban, Giving Lawmakers Time to Establish Legal Regulations

The U.S. Senate has rejected an amendment that would have enforced a federal ban on hemp-derived THC products scheduled for November, instead advancing a provision to delay the prohibition. This decision provides lawmakers additional time to develop comprehensive regulations that could keep legal THC products accessible to consumers and patients. Industry advocates view this delay as a critical opportunity to demonstrate the economic and potential therapeutic value of hemp-derived cannabinoids. The regulatory framework being developed will determine the future availability of these products for both recreational and medical users across the country.

yesterday
Marijuana Moment